20S proteasome plays a critical role in the regulation of several important cellular processes and has drawn extensive interest in the field of anti-tumor research. Peptide aldehydes can inhibit the 20S proteasome activity by covalently binding to the active site of the β subunits. In this work, covalent docking in conjunction with molecular dynamics (MD) simulation was used to explore the binding mode of MG132. Two conformations with the lowest docking energy were selected as the representative binding modes. One of the conformations was confirmed as a more reasonable binding mode by molecular dynamics simulations. The binding mode analysis revealed that a space demanding aromatic group with a short linker at the P4 site of the peptide aldehyde inhibitor would form favorable hydrophobic contacts with the neighboring subunit. A bulky substituent at the P2 position would also increase the binding stability by reducing water accessibility of the covalent bond. This study contributed to our understanding of the mechanism and structure-activity relationship of the peptide aldehyde inhibitors and may provide useful information for rational drug design.
机构:
Rabin Med Ctr, Inst Hematol, Petah Tiqwa, Israel
Tel Aviv Univ, Sackler Sch Med, Ramat Aviv, IsraelRabin Med Ctr, Inst Hematol, Petah Tiqwa, Israel
Muchtar, E.
Uziel, O.
论文数: 0引用数: 0
h-index: 0
机构:
Felsenstein Med Res Ctr, Petah Tiqwa, IsraelRabin Med Ctr, Inst Hematol, Petah Tiqwa, Israel
Uziel, O.
Shalem, N.
论文数: 0引用数: 0
h-index: 0
机构:
Felsenstein Med Res Ctr, Petah Tiqwa, IsraelRabin Med Ctr, Inst Hematol, Petah Tiqwa, Israel
Shalem, N.
Beery, E.
论文数: 0引用数: 0
h-index: 0
机构:
Felsenstein Med Res Ctr, Petah Tiqwa, IsraelRabin Med Ctr, Inst Hematol, Petah Tiqwa, Israel
Beery, E.
Nordenberg, Y.
论文数: 0引用数: 0
h-index: 0
机构:
Felsenstein Med Res Ctr, Petah Tiqwa, Israel
Rabin Med Ctr, Endocrinol Lab, Petah Tiqwa, Israel
Tel Aviv Univ, Sackler Sch Med, Dept Human Mol Genet & Biochem, Ramat Aviv, IsraelRabin Med Ctr, Inst Hematol, Petah Tiqwa, Israel
Nordenberg, Y.
Bakhanashvili, M.
论文数: 0引用数: 0
h-index: 0
机构:
Tel Hashomer Hosp, Sheba Med Ctr, Unit Infect Dis, Ramat Gan, IsraelRabin Med Ctr, Inst Hematol, Petah Tiqwa, Israel
Bakhanashvili, M.
Gutkin, A.
论文数: 0引用数: 0
h-index: 0
机构:
Felsenstein Med Res Ctr, Petah Tiqwa, IsraelRabin Med Ctr, Inst Hematol, Petah Tiqwa, Israel
Gutkin, A.
Lahav, M.
论文数: 0引用数: 0
h-index: 0
机构:
Tel Aviv Univ, Sackler Sch Med, Ramat Aviv, Israel
Rabin Med Ctr, Petah Tiqwa, IsraelRabin Med Ctr, Inst Hematol, Petah Tiqwa, Israel
机构:
China Pharmaceut Univ, Dept Med Chem, Nanjing 210009, Jiangsu, Peoples R ChinaChina Pharmaceut Univ, Dept Med Chem, Nanjing 210009, Jiangsu, Peoples R China
Li, Aibo
Sun, Haopeng
论文数: 0引用数: 0
h-index: 0
机构:
China Pharmaceut Univ, Jiangsu Key Lab Drug Design & Optimizat, Nanjing 210009, Jiangsu, Peoples R ChinaChina Pharmaceut Univ, Dept Med Chem, Nanjing 210009, Jiangsu, Peoples R China
Sun, Haopeng
Du, Lei
论文数: 0引用数: 0
h-index: 0
机构:
China Pharmaceut Univ, Dept Med Chem, Nanjing 210009, Jiangsu, Peoples R ChinaChina Pharmaceut Univ, Dept Med Chem, Nanjing 210009, Jiangsu, Peoples R China
Du, Lei
Wu, Xiaoxin
论文数: 0引用数: 0
h-index: 0
机构:
China Pharmaceut Univ, Dept Med Chem, Nanjing 210009, Jiangsu, Peoples R ChinaChina Pharmaceut Univ, Dept Med Chem, Nanjing 210009, Jiangsu, Peoples R China
Wu, Xiaoxin
Cao, Jianqin
论文数: 0引用数: 0
h-index: 0
机构:
China Pharmaceut Univ, Dept Med Chem, Nanjing 210009, Jiangsu, Peoples R ChinaChina Pharmaceut Univ, Dept Med Chem, Nanjing 210009, Jiangsu, Peoples R China
Cao, Jianqin
You, Qidong
论文数: 0引用数: 0
h-index: 0
机构:
China Pharmaceut Univ, Jiangsu Key Lab Drug Design & Optimizat, Nanjing 210009, Jiangsu, Peoples R ChinaChina Pharmaceut Univ, Dept Med Chem, Nanjing 210009, Jiangsu, Peoples R China
You, Qidong
Li, Yuyan
论文数: 0引用数: 0
h-index: 0
机构:
China Pharmaceut Univ, Jiangsu Key Lab Drug Design & Optimizat, Nanjing 210009, Jiangsu, Peoples R ChinaChina Pharmaceut Univ, Dept Med Chem, Nanjing 210009, Jiangsu, Peoples R China